* Orphan drug designation in European Union for GLPG1690 in
idiopathic pulmonary fibrosis
Source text for Eikon:
Further company coverage:
(Gdynia Newsroom:)
The post BRIEF-Galapagos gets orphan drug designation in EU for GLPG1690 in idiopathic pulmonary fibrosis appeared first on NASDAQ.